Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
126,748 studies indexed
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00591656 | Systemic Consolidation Therapy After Primary Chemoradiation Therapy for Locally Advanced Cervical Cancer | unknown | — | 69 | Seoul National University HospitalOTHER | 1 | Jan 11, 2008 | clinicaltrials |
| NCT00592059 | Systemic Consolidation Therapy After Chemoradiation Therapy Following Operation for High Risk Early Stage Cervical Cancer | unknown | — | 77 | Seoul National University HospitalOTHER | 1 | Jan 11, 2008 |
| clinicaltrials |
| NCT00141700 | Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma | terminated | Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00148135 | Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site | terminated | Phase 2 | — | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00176787 | Radiation Therapy With Capecitabine in Rectal Cancer | terminated | Phase 2 | 30 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00194467 | Suppression of Oral HHV8 Shedding With Valganciclovir | completed | Phase 2 | 32 | University of WashingtonOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00466089 | Study of 3D Radiotherapy With or Without Erlotinib (Tarceva®) in Patients With Localized Non-Small Cell Lung Cancer | unknown | Phase 2 | 90 | Hospital of NavarraOTHER | 1 | Jan 10, 2008 | clinicaltrials |
| NCT00580359 | S-1 vs Capecitabine in the Elderly and/or Poor Performance Status Patients With Recurrent or Metastatic Gastric Cancer | unknown | Phase 2 | 96 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 8, 2008 | clinicaltrials |
| NCT00587756 | Alternative to Two-Stage Hepatectomy | completed | — | 19 | University of MilanOTHER | 1 | Jan 8, 2008 | clinicaltrials |
| NCT00040092 | A Study to Test the Effectiveness of Virulizin® Given in Combination With Standard Chemotherapy for Pancreatic Cancer | completed | Phase 3 | 400 | Aptose Biosciences Inc.INDUSTRY | 0 | Jan 7, 2008 | clinicaltrials |
| NCT00056173 | Combination of Capecitabine and GTI-2040 in the Treatment of Renal Cell Carcinoma | completed | Phase 1 / Phase 2 | 43 | Aptose Biosciences Inc.INDUSTRY | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00393809 | Safety and Proof of Concept Study of Intravesical DTA-H19 in Patients With Superficial Bladder Cancer | completed | Phase 1 / Phase 2 | 18 | Hebrew University of JerusalemOTHER | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00515190 | Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma | unknown | Phase 2 | 198 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00587145 | Phase II Study of Perioperative S-1 Plus Docetaxel in Patients With Localized Advanced Gastric Cancer | unknown | Phase 2 | 44 | National Cancer Center, KoreaOTHER_GOV | 1 | Jan 7, 2008 | clinicaltrials |
| NCT00157560 | Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma | completed | Phase 2 | 83 | Massachusetts General HospitalOTHER | 1 | Jan 3, 2008 | clinicaltrials |
| NCT00197925 | Dendritic Cell Based Therapy of Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 40 | Herlev HospitalOTHER | 1 | Jan 3, 2008 | clinicaltrials |
| NCT00226668 | XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema | withdrawn | Phase 3 | 120 | Celtic Pharma Development ServicesINDUSTRY | 2 | Jan 3, 2008 | clinicaltrials |
| NCT00328588 | LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy | completed | Phase 2 | 37 | Astellas Pharma IncINDUSTRY | 3 | Jan 2, 2008 | clinicaltrials |
| NCT00584792 | Diet, Genetic Variation and Prostate Cancer Among African Americans | completed | — | 102 | University of California, DavisOTHER | 0 | Jan 2, 2008 | clinicaltrials |
| NCT00005007 | Etanercept for Wegener's Granulomatosis | completed | Phase 2 / Phase 3 | 181 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)NIH | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00044902 | Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade) | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 28, 2007 | clinicaltrials |
| NCT00077493 | BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | suspended | Phase 1 | 95 | MedImmune LLCINDUSTRY | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00117624 | A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy | completed | Phase 3 | — | AmgenINDUSTRY | 0 | Dec 28, 2007 | clinicaltrials |
| NCT00119470 | EUS-FNA in the Pre-Operative Evaluation of Patients With Lung Cancer | completed | Phase 2 | 40 | University Hospital, GhentOTHER | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00148655 | Educational Interventions for Patients With DCIS | completed | N/A | 120 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00165087 | Treatment of Childhood Acute Lymphoblastic Leukemia | terminated | Phase 3 | 491 | Dana-Farber Cancer InstituteOTHER | 3 | Dec 28, 2007 | clinicaltrials |
| NCT00165100 | Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer | completed | N/A | 50 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00165373 | rhEndostatin Protein Involving Pediatric Patients With Cancer | terminated | Phase 1 | 21 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00262444 | Effectivity and Efficiency of Turning Frequencies: a Randomised Controlled Trial | completed | N/A | 500 | University GhentOTHER | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00286000 | High Dose Simplified Folfiri in Advanced Colorectal Cancer: a Multicentre Phase II Study | completed | Phase 2 | 106 | University Hospital, GhentOTHER | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00417677 | A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma | terminated | Phase 1 / Phase 2 | 124 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 28, 2007 | clinicaltrials |
| NCT00582244 | Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized Trial(EVA project) | unknown | Phase 3 | 325 | The Netherlands Cancer InstituteOTHER | 0 | Dec 28, 2007 | clinicaltrials |
| NCT00146211 | TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease | completed | Phase 3 | 300 | Amarin Neuroscience LtdINDUSTRY | 2 | Dec 27, 2007 | clinicaltrials |
| NCT00195299 | Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck | completed | — | 20 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 27, 2007 | clinicaltrials |
| NCT00235794 | An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer Patients | completed | N/A | 50 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 27, 2007 | clinicaltrials |
| NCT00034346 | ABX-EGF in Combination With Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | 194 | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00089726 | A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 100 | Cell GenesysINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00116441 | Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma | completed | Phase 1 / Phase 2 | 22 | Cell GenesysINDUSTRY | 1 | Dec 24, 2007 | clinicaltrials |
| NCT00116467 | Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia | completed | Phase 2 | 55 | Cell GenesysINDUSTRY | 1 | Dec 24, 2007 | clinicaltrials |
| NCT00120679 | Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00120692 | Treatment for Patients Suffering From Anemia Due to Chemotherapy | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00121030 | Treatment for Patients With Gynecological Malignancies Who Suffer From Anemia Due to Chemotherapy | completed | Phase 2 | — | AmgenINDUSTRY | 0 | Dec 24, 2007 | clinicaltrials |
| NCT00140348 | Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine | completed | Phase 1 / Phase 2 | 80 | Cell GenesysINDUSTRY | 1 | Dec 24, 2007 | clinicaltrials |
| NCT00501332 | Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy | unknown | Phase 2 | 30 | Maxygen Holdings Ltd.INDUSTRY | 4 | Dec 24, 2007 | clinicaltrials |
| NCT00580450 | Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies | unknown | Phase 1 / Phase 2 | 9 | University Of PerugiaOTHER | 1 | Dec 24, 2007 | clinicaltrials |
| NCT00069875 | A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer | completed | Phase 2 | 195 | Eli Lilly and CompanyINDUSTRY | 6 | Dec 21, 2007 | clinicaltrials |
| NCT00086216 | Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma | completed | Phase 1 / Phase 2 | 30 | Callisto PharmaceuticalsINDUSTRY | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00116506 | Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer | completed | Phase 2 | 35 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 21, 2007 | clinicaltrials |
| NCT00121095 | Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancer | unknown | Phase 1 / Phase 2 | 69 | Cytogen CorporationINDUSTRY | 1 | Dec 21, 2007 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials